Pfizer Inc. 13D and 13G filings for Cerevel Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-05 6:12 pm Sale | 2024-08-01 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 0 0.000% | -27,349,211 (Position Closed) | Filing |
| 2023-10-18 4:27 pm Unchanged | 2023-10-12 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 27,349,211 15.400% | 0 (Unchanged) | Filing |
| 2022-04-07 4:51 pm Unchanged | 2022-03-31 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 27,349,211 18.500% | 0 (Unchanged) | Filing |
| 2021-09-17 4:27 pm Unchanged | 2021-09-10 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 27,349,211 18.900% | 0 (Unchanged) | Filing |
| 2021-07-09 4:16 pm Unchanged | 2021-07-01 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 27,349,211 19.400% | 0 (Unchanged) | Filing |
| 2020-11-06 4:10 pm Purchase | 2020-10-27 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 27,349,211 21.500% | 27,349,211 (New Position) | Filing |